Navigation Links
Center for AIDS Research at Emory University to Serve as Local Host of AIDS Vaccine 2010
Date:9/14/2009

Atlanta to Serve as Stage for Premier Discussion on HIV Vaccine Development

NEW YORK, Sept. 14 /PRNewswire-USNewswire/ -- The Global HIV Vaccine Enterprise (the Enterprise) today announced that the Center for AIDS Research at Emory University (CFAR) in Atlanta, Georgia will serve as Local Host of AIDS Vaccine 2010, the largest and most important global scientific conference focused on AIDS vaccine research. AIDS 2010 is to be held September 28 to October 1, 2010. This annual international conference brings together scientists, community advocates, funders, and policy makers from around the world to hear cutting edge scientific results, exchange new ideas, educate future leaders, and engage a diverse community of scientists in the quest for an HIV vaccine.

"The Global HIV Vaccine Enterprise is committed to accelerating the search for a safe and effective vaccine through scientific collaboration and global initiatives that bring together the world's best researchers, scientific organizations, advocates, funders, and policy makers for common purpose," said Alan Bernstein, Ph.D., executive director, Global HIV Vaccine Enterprise. "Our annual AIDS Vaccine conference is one such initiative and we look forward to collaborating with the Center for AIDS Research at Emory University to plan and implement the premier conference dedicated to HIV vaccine research."

AIDS Vaccine 2010 will feature daily plenary presentations by leading researchers, clinicians, and community advocates, and oral and poster presentations of hundreds of research papers addressing every aspect of HIV vaccine development and testing. The conference is expected to attract more than 1,000 researchers, clinicians, and community advocates from around the world to Atlanta.

Eric Hunter, Ph.D., Georgia Research Alliance eminent scholar and co-director, Center for AIDS Research at Emory University will chair AIDS Vaccine 2010 with support from the following co-chairs: James Curran, M.D., MPH, dean, Rollins School of Public Health and co-director, Center for AIDS Research, Emory University; Carlos del Rio, M.D., Hubert chair, department of Global Health, Rollins School of Public Health and co-director, Center for AIDS Research, Emory University; and Harriet Robinson, Ph.D., senior vice president of research and development, GeoVax, former director, division of Microbiology and Immunology, Yerkes National Primate Research Center, Emory University.

"The Center for AIDS Research at Emory University is pleased to host the AIDS Vaccine 2010 conference in Atlanta. Because Atlanta is the epicenter for the HIV/AIDS pandemic in the Southeast, the development of a viable vaccine is a very relevant objective for our community," said Eric Hunter, Ph.D., whose research is conducted at the Emory Vaccine Center. "The devastation of HIV/AIDS is well known, and the need for continued scientific inquiry and global awareness of the disease remains critical in the quest for an effective HIV vaccine."

AIDS Vaccine 2010 aims to help cultivate a global network of scientific talent to carry the field of HIV vaccine research into the future. AIDS Vaccine 2010 will welcome a large cohort of promising early career scientists both nationally and internationally through conference scholarships and travel support.

AIDS Vaccine 2009, with the French National Agency for Research on AIDS and Viral Hepatitis (ANRS) serving as Local Host, will be held in Paris, France from October 19 to 22, 2009. AIDS Vaccine 2008 was held in Cape Town, South Africa.

More information on the AIDS Vaccine conference is available at http://www.hivvaccineenterprise.org/conference/2009/index.aspx.

About the Organizers:

The Global HIV Vaccine Enterprise (the Enterprise) is a one-of-a-kind alliance of independent organizations around the world dedicated to accelerating the development of a preventive HIV vaccine. The Enterprise, comprised of top research, funding, advocacy and other stakeholder organizations, develops and drives implementation of the Scientific Strategic Plan for HIV vaccine development. In support of this Plan, Enterprise stakeholders are setting shared research agendas, creating new structures for information sharing, developing new tools to harmonize global research efforts, and bringing new organizations, expertise and money to the challenge. The Enterprise organizes the world's leading HIV vaccine research conference, AIDS Vaccine, annually. For more information, please visit www.hivvaccineenterprise.org.

The Center for AIDS Research at Emory University (CFAR) is one of 20 National Institutes of Health funded centers across the United States. The CFAR at Emory facilitates clinical, prevention, vaccine, and basic science HIV/AIDS research for more than 120 investigators at Emory and its Atlanta partner institutions. The Emory Vaccine Center (EVC) supports strong pre-clinical and clinical HIV vaccine research programs. Atlanta's Emory University, ranked as one of the country's top national universities, encompasses nine undergraduate, graduate, and professional schools with a total enrollment of 12,755 students. Emory's Robert W. Woodruff Health Sciences Center is an academic health science and service center focused on missions of teaching, research, health care, and public service. Its components are Emory University School of Medicine, Nell Hodgson Woodruff School of Nursing, and Rollins School of Public Health; Yerkes National Primate Research Center; Emory Winship Cancer Institute; the Emory Vaccine Center; and Emory Healthcare, the largest, most comprehensive health system in Georgia. For more information, please visit www.emory.edu, www.cfar.emory.edu and http://vaccines.emory.edu/.


'/>"/>
SOURCE Global HIV Vaccine Enterprise
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Joint Center to Unveil Health Reform Study Providing Answers: What Is the Cost of Not Addressing Racial Health Disparities?
2. Celebrating Five Years of Advanced Care Excellence: Maria Fareri Childrens Hospital at Westchester Medical Center Reaches a Milestone
3. Dr. Eliscer Guzman, with The Mount Sinai Medical Center, Join Forces to Celebrate the Community Diabetes and Cardiovascular Care Programs Graduation Ceremony on September 16th
4. Memorial Blood Centers Issues a Critical Alert For Blood Donations
5. BayCare Outpatient Center Opens in Westchase, Florida
6. Sleep HealthCenters and Southcoast Hospitals Group Expand Patient Services in North Dartmouth
7. New Mobile STAR Cranial Center of Excellence Vehicle Brings Cutting-Edge Treatment to Satellite Communities
8. Technologies That Redefine Care for Older Americans to be Focus of Conference Session Led by Center for Technology and Aging
9. SEIU Local 721 Calls for Attorney General to Investigate Self-Dealing and $22 Million in Extra Costs at Tarzana Treatment Center
10. HRSA Releases $24.5 Million in Grants to Support Poison Control Centers
11. Wed., Sept. 16, 11 AM News Conference: Sioux Falls Keystone Treatment Center Is National HQ to Lead 100 Locations Nationwide in Balloon Liftoff Celebrating Recovery Against New Wave of Drug Abuse; Former U.S. Drug Czar/4-Star Gen. Barry McCaffrey, Lieute
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... 23, 2017 , ... PAINWeekEnd (PWE) Oklahoma City, on April ... will be an educational and exciting program providing busy clinicians and allied healthcare ... pain. , Oklahoma is in a healthcare crisis. The state ranks 46th in ...
(Date:3/23/2017)... ... , ... The MBI “Hall of Fame” recognizes the contributions of those whose careers are or ... the careers of all others involved. , On Monday, March 21st, 2017 Laurie ... of Fame. The induction took place during the World of Modular – Award Gala ...
(Date:3/23/2017)... OH (PRWEB) , ... March ... ... insurance and financial services firm serving the families and businesses of the ... community enrichment program. Northern Ohio Recovery Center (N.O.R.A.) is a nonprofit, community-based ...
(Date:3/23/2017)... GA (PRWEB) , ... March 23, 2017 , ... ... the release of SmartBen NOW, an innovative mobile app and centralized benefits dashboard ... and present critical information securely from multiple locations. For the first time, employees ...
(Date:3/23/2017)... ... March 23, 2017 , ... Hakim ... based healthcare technology company California Healthcom Group (CHG). , The HUG investment ... arena. With headquarters in California, CHG is a growing, internationally recognized healthcare management, ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... LONDON , March 23, 2017 ... comprehensive research report created through extensive primary research ... research, the report aims to present the analysis ... basis of Procedure (Replacement and Repair); Replacement Procedure ... (TAVR)), Repair By Technique (Surgical Devices, Balloon Valvuloplasty, ...
(Date:3/23/2017)... LONDON , March 23, 2017 ... the years along with the prevalence of allergic ... preventative measures are currently revolutionising the ways in ... Allergies 2017 promises to be both ... discussion amongst the allergy interest groups, immunologists, research ...
(Date:3/23/2017)... March 23, 2017 ... Healthcare disease pipeline guide Primary Hyperoxaluria - Pipeline ... Primary Hyperoxaluria (Genito Urinary System And Sex Hormones) ... condition characterized by recurrent kidney and bladder stones. ... called oxalate. Symptoms include blood in the urine, ...
Breaking Medicine Technology: